
-
In Simandou mountains, Guinea prepares to cash in on iron ore
-
Morikawa says not to blame for 'rude' Ryder Cup fans
-
Far right harvests votes as climate rules roil rural Spain
-
'Return to elegance': highlights from Paris Fashion Week
-
Britain's storied Conservative party faces uncertain future
-
New Zealand's seas warming faster than global average: report
-
Snakebite surge as Bangladesh hit by record rains
-
Yankees deny Blue Jays playoff sweep as Mariners beat Tigers
-
Australia police foil 'kill team' gang hit near daycare centre
-
US, Qatar, Turkey to join third day of Gaza peace talks in Egypt
-
Gold tops $4,000 for first time as traders pile into safe haven
-
Indian garment exporters reel under US tariffs
-
NBA back in China after six-year absence sparked by democracy tweet
-
Energy storage and new materials eyed for chemistry Nobel
-
Trump unlikely to win Nobel Peace Prize, but who will?
-
Qatar, Turkey to join third day of Gaza peace talks in Egypt
-
Study finds women have higher genetic risk of depression
-
Dolly Parton's sister calls for fan prayers over health issues
-
On Trump's orders, 200 troops from Texas arrive in Illinois
-
Two bodies found, two missing after Madrid building collapse
-
Panthers raise banner as NHL three-peat bid opens with win
-
Nobel physics laureate says Trump cuts will 'cripple' US research
-
UFC star McGregor suspended 18 months over missed drug tests
-
Trump talks up Canada trade deal chances with 'world-class' Carney
-
Ecuador president unharmed after apparent gun attack on motorcade
-
Lyon exact revenge on Arsenal, Barca thrash Bayern in women's Champions League
-
Trump says 'real chance' to end Gaza war as Israel marks attacks anniversary
-
Gerrard brands failed England generation 'egotistical losers'
-
NFL fines Cowboys owner Jones $250,000 over gesture to fans
-
Bengals sign veteran quarterback Flacco after Burrow injury
-
New prime minister inspires little hope in protest-hit Madagascar
-
Is Trump planning something big against Venezuela's Maduro?
-
EU wants to crack down on 'conversion therapy'
-
French sex offender Pelicot says man who abused ex-wife knew she was asleep
-
Trump says 'real chance' to end Gaza war as Israel marks Oct 7 anniversary
-
UK prosecutors to appeal dropped 'terrorism' case against Kneecap rapper
-
Spain, Inter Miami star Alba retiring at end of season
-
EU targets foreign steel to rescue struggling sector
-
Djokovic vanquishes exhaustion to push through to Shanghai quarters
-
Trump talks up Canada deal chances with visiting PM
-
Knight rides her luck as England survive Bangladesh scare
-
Pro-Gaza protests flare in UK on anniversary of Hamas attack
-
Top rugby unions warn players against joining rebel R360 competition
-
Outcast Willis 'not overthinking' England absence despite Top 14 clean sweep
-
Trump says 'real chance' of Gaza peace deal
-
Macron urged to quit to end France political crisis
-
No.1 Scheffler seeks three-peat at World Challenge
-
Canadian PM visits Trump in bid to ease tariffs
-
Stocks falter, gold shines as traders weigh political turmoil
-
Senators accuse US attorney general of politicizing justice

New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards
NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / New to The Street, the nation's premier financial media platform for emerging public companies, proudly announces a major media partnership with NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI). Under this agreement, NeOnc will be featured in a 12-part national broadcast series, with exclusive monthly interviews airing on Bloomberg Television and Fox Business Network. The series will also include earned media distribution, commercial rotation across national networks, and outdoor billboard campaigns in the most visible financial corridors in the U.S.
This partnership launches at a pivotal time for NeOnc Technologies, following two significant corporate milestones:
The signing of a Letter of Intent to acquire breakthrough intellectual property (IP) for brain cancer treatment, positioning the company at the forefront of neuro-oncology innovation;
The execution of a $50 million definitive strategic partnership with Quazar Investment, accelerating NeOnc's operational and clinical development roadmap.
Breakthrough Science Meets Breakthrough Exposure
The integrated media campaign includes:
12 Long-Form Network Broadcast Interviews from the Nasdaq and NYSE studios on Bloomberg TV and Fox Business as sponsored programming.
More than 300 Monthly Commercial Spots across targeted investor and innovation-focused time blocks.
Earned Media Coverage on major U.S. networks via NewsOut™, including CBS, NBC, and ABC affiliates.
Iconic Billboard Placements in Times Square (Nasdaq Tower and Reuters Boards), NYC Financial District shelters, and premium taxi tops.
Digital Amplification via YouTube and social platforms:
New to The Street TV Channel: youtube.com/@NewtotheStreetTV
NewsOut Channel: youtube.com/@newsoutchannel
Executive Commentary
"NeOnc is entering a new era, not only in terms of medical science but also visibility in the public markets. Their latest IP acquisition and $50 million partnership with Quazar reflect serious momentum," said Vince Caruso, Founder and CEO of New to The Street. "We're proud to provide a media platform that matches their global ambitions and innovations with real-world distribution, every month."
About NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI)
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on the development and commercialization of central nervous system therapeutics that are designed to address the persistent challenges in overcoming the blood-brain barrier. The company's NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas.
NeOnc's lead therapeutics, NEO100™ and NEO212™, are currently in Phase II human clinical trials and advancing under FDA Fast-Track and Investigational New Drug (IND) status. The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California, consisting of issued patents and pending applications related to NEO100, NEO212, and other candidates from the NeOnc patent family for multiple uses, including oncological and neurological conditions.
To learn more, visit https://www.neonc.com.
About New to The Street
Since 2009, New to The Street has been a leading force in financial media, showcasing public and private companies through its unmatched mix of national television broadcasts, digital syndication, and social media reach. With over 3.2 million subscribers on the New to The Street TV YouTube channel and a combined following of more than 511,000 across LinkedIn, Facebook, Instagram, and X, the platform delivers consistent visibility to investors, industry leaders, and the general public.
New to The Street offers more linear "real TV" broadcast distribution than any other outlet in the space, with long-running placements across Bloomberg TV, Fox Business Network, and other national platforms. Its "Opportunities to Consider™" segments and in-depth executive interviews have become a trusted source for market-moving narratives, emerging growth stories, and thought leadership across finance, tech, biotech, and beyond.
Learn more:
Website: https://www.newtothestreet.com
YouTube: youtube.com/@NewtotheStreetTV
NewsOut Channel: youtube.com/@newsoutchannel
Media Contact:
Monica Brennan
Head of Communications, New to The Street
[email protected]
SOURCE: New To The Street
View the original press release on ACCESS Newswire
P.M.Smith--AMWN